BSE filing, NSE: ALFATRAN. Summary written from the filing by ALFA Finder's alert engine.
Alfa Transformers Ltd: key numbers
- Share price
- ₹52.95
- Market cap
- ₹48.45 Cr
- Revenue (annual)
- ₹31.87 Cr
- Net profit (annual)
- ₹-1.59 Cr
- P/E (TTM)
- 34.4×Sector 40.5×
- Promoter holding
- 46.92%+0.11% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alfa Transformers Ltd
All →Alfa Transformers Q2 FY27 Results: Turns Profitable, Net Profit ₹2.7 Cr
Alfa Transformers Ltd reported revenue from operations of ₹22.5 Cr (+294.7% YoY) and net profit of ₹2.7 Cr for Q2 FY27.
- Key figure
- Net profit ₹2.7 Cr
Alfa Transformers Board Meeting Date
Alfa Transformers Ltd intimated a board/Audit Committee meeting on 27 Oct 2026 to consider unaudited H1 FY27 standalone results. No financial figures are disclosed in this advance notice.
Alfa Transformers Other Announcement
Alfa Transformers Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, as required under SEBI regulations.
Alfa Transformers Promoter Buying
Promoter group entity D.K. Das & Sons HUF purchased 1,000 equity shares of Alfa Transformers Ltd via an open market transaction on September 30, 2026.
- Promoter stake change
- +0.01%
Alfa Transformers Promoter Buying: ₹0.01 Cr
Promoter Geetishree Das purchased 3,200 equity shares of Alfa Transformers Ltd worth ₹0.01 Crore from the open market, increasing stake by 0.023%.
- Value
- ₹0.01 Cr
- Promoter stake change
- +0.02%
Alfa Transformers Promoter Buying: ₹0.02 Cr
Alfa Transformers promoters Industrial Designs and Dillip Kumar Das bought 7,000 shares on-market on Sept 21. Total cost was ₹0.02 Crore.
- Value
- ₹0.02 Cr
- Promoter stake change
- +0.05%
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr